Is Appili Therapeutics Inc (APLIF) a Buy, Sell, or Hold?
OTC : APLIF
Appili Therapeutics Inc
$0.0078 USD
$0.0 (-2.5%)
- Volume
- 80K
- Average Volume
- 36.06K
- Market Capitalization
- $1.03M
- P/E Ratio
- -0.30
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.03
- Year Low
- $0.01
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.11
Company Overview
OTC
Don Cilla
Biotechnology
Healthcare
APLIF
7
CA
USD
Liquidity Metrics
-0.75
0.11
0.11
0.00
0.00
Sales & Valuation
$244.81K
5.07
-0.08
-1.00
-0.01
Profitability
-$0.0344
-$4.25M
-1622.17%
-1577.48%
26.47%
-214.47%
P/E Metrics
-0.30
0.01
0.01
Analyst Price Target & Rating
2/5
0 Analysts
%
Financial Health Scores
-72.16
3/9
-$16.71M
$1.98M
$19.35M
-$4.99M
Key Metrics (TTM)
$14.22M
54.50
-2.86
0.11
26.47%
125.67%
-319.75%
-100.01%
-274058 days
Company Executives
| Name | Title |
|---|---|
| Carl Gelhaus | Director of Non-Clinical Research |
| Donald D. Cilla Jr. Pharmd | Chief Executive Officer, President & Director |
| Jenna McNeil | Corporate Affairs & Communications Manager |
| Arthur Baran | Director of New Product Development |
| Kenneth G. Howling | Acting Chief Financial Officer |
| Gary S. Nabors | Chief Development Officer |
Poll Results
No votes yet today — be the first to share your view!
About Appili Therapeutics Inc (OTC:APLIF) Stock
Appili Therapeutics, Inc. operates as a biopharmaceutical company, which acquires and develops novel treatments targeting unmet needs in infectious disease. It focuses on building and advancing a diverse portfolio of anti-infective programs such as ATI-1501, ATI-1503, and ATI-1701. The company was founded on May 7, 2015 and is headquartered in Halifax, Canada. ...
2026-07-03 18:10:00
HALIFAX, Nova Scotia, July 03, 2026 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases today announced that it has received a Notice of Termination for Convenience from the National Institute of Allergy and Infectious Diseases (“NIAID”), part of the National Institutes of Health (“NIH”), in connection with the Company's contract supporting development of the VXV-01 fungal vaccine candidate.
Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results
2026-06-26 18:29:00
LIKMEZ® (ATI-1501) commercial momentum building in U.S. market US$40 million NIAID award supporting VXV-01 advancement through Phase 1
Frequently Asked Questions
-
What is the current Appili Therapeutics Inc (APLIF) stock price?
-
Appili Therapeutics Inc(OTC:APLIF) stock price is $0.0078 in the last trading session. During the trading session, APLIF stock reached the peak price of $0.031 while $0.0076 was the lowest point it dropped to. The percentage change in APLIF stock occurred in the recent session was --2.5% while the dollar amount for the price change in APLIF stock was -$0.0.
-
APLIF's industry and sector of operation?
-
The OTC listed APLIF is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of APLIF?
-
Carl Gelhaus | Director of Non-Clinical Research
Donald D. Cilla Jr. Pharmd | Chief Executive Officer, President & Director
Jenna McNeil | Corporate Affairs & Communications Manager
Arthur Baran | Director of New Product Development
Kenneth G. Howling | Acting Chief Financial Officer -
How many employees does APLIF have?
-
Number of APLIF employees currently stands at 7. APLIF operates from 1344 Summer Street, Halifax, NS B3H 0A8, CA.
-
Link for APLIF official website?
-
Official Website of APLIF is: http://www.appilitherapeutics.com
-
How do I contact APLIF?
-
APLIF could be contacted at phone #902-442-4655 and can also be accessed through its website. APLIF operates from 1344 Summer Street, Halifax, NS B3H 0A8, CA.
-
How many shares of APLIF are traded daily?
-
The average number of APLIF shares traded daily for last 3 months was 36.06K.
-
What is the market cap of APLIF currently?
-
The market value of APLIF currently stands at $1.03M with its latest stock price at $0.0078